At Virginia Women's Center, we currently have the following clinical research study enrolling:

1. Overactive bladder study

Classification: New compound of recombinant fusion protein

Type: Placebo-controlled, randomized, double blind - meaning a computer assigns the medication number; we have no knowledge of whether it is placebo or actual drug

Length of study: Up to 28 weeks including screening period with nine clinic visits

Major inclusion criteria:

  1. 18-75 years of age with no possibility of becoming pregnant.
  2. Have not been successfully managed on other medications for overactive bladder because of side effects associated with those medications or because they were not effective.
  3. Must have a confirmed diagnosis of overactive bladder for at least six months.
  4. Not currently taking any antibiotics to prevent urinary tract infections.
  5. Less than two urinary tract infections in the past six months.
  6. No surgery for incontinence or other pelvic surgeries such as sling procedure, uterine prolapsed, rectocele or cystocele, etc.


If you are interested in being considered for a future study, fill out the "add my name to the clinical research database" form. By signing this form, you are allowing us to contact you in the event that we conduct a study of interest to you and to review your medical chart for diagnoses and medications that may be relevant to the study. Your completion of this form does NOT obligate you to participate in a study.

Contact a clinical research coordinator at 804.662.6117 or send a secure message on our patient portal to learn more or express interest in participating in one of our current studies.

For more information, return to the clinical research page.